These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32510004)

  • 1. Improving the efficiency of clinical trials by standardizing processes for Investigator Initiated Trials.
    Mudaranthakam DP; Phadnis MA; Krebill R; Clark L; Wick JA; Thompson J; Keighley J; Gajewski BJ; Koestler DC; Mayo MS
    Contemp Clin Trials Commun; 2020 Jun; 18():100579. PubMed ID: 32510004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Industry-Sponsored Trials (IST) and Investigator-Initiated Trials (IIT) in Advanced Genitourinary Cancers in the United States, Canada, United Kingdom and France.
    Wong B; Peng J; Jiang DM; Fizazi K; Powles T; James N; Sridhar SS
    Clin Genitourin Cancer; 2024 Dec; 22(6):102210. PubMed ID: 39299034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Investigator-Initiated Trials between Japan and Other Countries: Analyses of Clinical Trials Sponsored by Academia and Government in the ClinicalTrials.gov Registry and in the Three Japanese Registries.
    Ito T
    PLoS One; 2016; 11(2):e0148455. PubMed ID: 26848574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Successful Synchronized Orchestration of an Investigator-Initiated Multicenter Trial Using a Clinical Trial Management System and Team Approach: Design and Utility Study.
    Mudaranthakam DP; Brown A; Kerling E; Carlson SE; Valentine CJ; Gajewski B
    JMIR Form Res; 2021 Dec; 5(12):e30368. PubMed ID: 34941552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Panoramic quality assessment tool for investigator initiated trials.
    Lv W; Hu T; Jiang J; Qu T; Shen E; Duan J; Miao X; Zhang W; Qian B
    Front Public Health; 2022; 10():988574. PubMed ID: 36176521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The landscape of investigator-initiated oncology trials conducted in mainland China during the past decade (2010-2019).
    Cao Y; Ye LM; Fan Z; Yang W; Chen LY; Mei Y; He DY; Mo WJ
    Cancer Innov; 2023 Feb; 2(1):79-90. PubMed ID: 38090374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Development of Investigator-Initiated Clinical Trials in Surgical Oncology.
    McDonald HG; Cassim EB; Harper MM; Burke EE; Marcinkowski EF; Cavnar MJ; Pandalai PK; Kim J
    Surg Oncol Clin N Am; 2023 Jan; 32(1):13-25. PubMed ID: 36410913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design.
    Nury E; Bischoff K; Wollmann K; Nitschke K; Lohner S; Schumacher M; Rücker G; Blümle A
    BMC Med Res Methodol; 2020 Oct; 20(1):246. PubMed ID: 33008297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigational medicinal products, related costs and hospital pharmacy services for investigator-initiated trials: A mixed-methods study.
    Taji Heravi A; Henn A; Deuster S; McLennan S; Gloy V; Mitter VR; Briel M;
    PLoS One; 2022; 17(3):e0264427. PubMed ID: 35245312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons learned from investigator-initiated clinical trials for localized pancreatic cancer.
    Tsai S; Evans DB
    J Surg Oncol; 2022 Jan; 125(1):69-74. PubMed ID: 34897709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of Directive 2001/20/EC for investigator-initiated trials in the paediatric population--a field report.
    Welzing L; Harnischmacher U; Weyersberg A; Roth B
    Eur J Pediatr; 2007 Nov; 166(11):1169-76. PubMed ID: 17333274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Status and Challenges of Cancer Clinical Trials in Korea.
    Shim BY; Park SH; Lee S; Kim JS; Lee KE; Kang YK; Ahn MJ
    Cancer Res Treat; 2016 Jan; 48(1):20-7. PubMed ID: 25761486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group.
    Kim BJ; Maeng CH; Keam B; Im YH; Ro J; Jung KH; Im SA; Kim TW; Lee JL; Heo DS; Kim SW; Park K; Ahn MJ; Cho BC; Kim HK; Kang YK; Cho JY; Yun HJ; Nam BH; Zang DY
    Cancer Res Treat; 2024 Jul; ():. PubMed ID: 38993093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creating and Implementing a Principal Investigator Tool Kit for Enhancing Accrual to Late Phase Clinical Trials: Development and Usability Study.
    Higgins KA; Thomas A; Soto N; Paulus R; George TJ; Julian TB; Hartson Stine S; Markham MJ; Werner-Wasik M
    JMIR Cancer; 2022 Aug; 8(3):e38514. PubMed ID: 36006678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent innovations in the USA National Cancer Institute-sponsored investigator initiated Phase I and II anticancer drug development.
    Bando H; Takebe N
    Jpn J Clin Oncol; 2015 Nov; 45(11):1001-6. PubMed ID: 26423340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Investigator-Initiated Clinical Trials with a Pharmaceutical for Cancer Patients before and after Post-Millennial Changes of Regulations in Germany and Europe.
    Berdel WE
    Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers.
    Herfarth HH; Jackson S; Schliebe BG; Martin C; Ivanova A; Anton K; Sandler RS; Long MD; Isaacs KL; Osterman MT; Sands BE; Higgins PD; Lewis JD
    Inflamm Bowel Dis; 2017 Jan; 23(1):14-22. PubMed ID: 27598744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accrual Prediction Program: A web-based clinical trials tool for monitoring and predicting accrual for early-phase cancer studies.
    Liu J; Wick JA; Mudaranthakam DP; Jiang Y; Mayo MS; Gajewski BJ
    Clin Trials; 2019 Dec; 16(6):657-664. PubMed ID: 31451012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.